Morning mooers! It's Tuesday, June 11th. The market hit highs yesterday and is pulling back, the story of June so far.
My name is Kevin Travers, here are stories from the herd on Wall Street today.
$Apple (AAPL.US)$ was the highest gainer on the S&P 500 and Dow up about 3% after investors sold the news Monday when the firm announced Apple Intelligence- upgrades to Sirir that use GTP 4 to help answer questions a...

Monring mooers! It is Friday, May 24th, the eve of Memorial Day weekend here in the U.S. The tech sector is in the green, the market is climbing. My name is Kevin Travers, I am writing from the beach today: here are stories moving the market.
$Magnite (MGNI.US)$ climbed about 14% after a Bank of American Research upgrade to buy. The stock was the highest advancer on the S&P 500.
$Intuit (INTU.US)$ was the lowest decliner on t...

$BioVie(BIVI.US)$
NEWS
BioVie’s Bezisterim Demonstrates Potential Improvements in Sleep/Fatigue and Restless Leg Symptoms for Parkinson’s Disease Patients
BioVie announced promising results from a Phase 2a trial of their drug bezisterim for Parkinson's disease. Data presented at the XXIX World Congress on Parkinson's Disease and Related Disorders showed that patients treated with bezisterim in combination with levodopa/carbidopa experienced significant improvements in both motor and non-motor s...

Financial giants have made a conspicuous bearish move on $Boeing(BA.US)$, Benzinga reported, citing eight unusual trades. About 62% of the trades showed bearish tendencies, while 25% were bullish, according to the report. Six of them were puts, with a value of $299,540, and 2 were calls, valued at $149,391, it said.
The trading activity signals investors are aiming for a price that ranges from $160 to $250 for Boeing shares over t...